Electronic Intervention to Chronic Opioid Therapy

Not Applicable

Completed

• Conditions: Chronic Opioid Therapy
• Interventions: Other: opioid prescribing

• Registration Number: NCT04198961
• Lead Sponsor: Stanford University

Brief Summary

This pilot study will attempt to apply an electronic chart intervention to improve safety for patients on chronic opioid medications.

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2019-12-09
• Study First Submitted QC: 2019-12-12
• Study First Posted: 2019-12-13
• Study Start: 2020-06-17
• Primary Completion: 2021-06-17
• Study Completion: 2021-06-17
• Status Verified: 2021-11
• Last Update Submitted: 2021-11-05
• Last Update Posted: 2021-11-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 43

Inclusion Criteria

• Patients prescribed long-term opioid therapy of doses greater than 90 morphine equivalent daily dose (MEDD)

Read More

Exclusion Criteria

• Patients prescribed short-term opioid medications for acute pain (less than a 90-day supply over the past 120 days), sublingual buprenorphine, methadone maintenance for opioid use disorder or with oncology or palliative care diagnoses will be excluded.

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Electronic Intervention	opioid prescribing	Individualized opioid taper and safety recommendations will be communicated to prescribers via an electronic medical record encrypted message.

Primary Outcome Measures

Name	Time	Method
Change in the number of patients who receives naloxone prescription	baseline, 1, 3- and 6-months and 12 months	Change in the number of patients who receives naloxone prescription
change of number of documentation about safety discussions	baseline, 1, 3- and 6-months and 12 months	change of number of documentation about safety discussions
change of number of order for urine toxicology screening	baseline, 1, 3- and 6-months and 12 months	change of number of order for urine toxicology screening
change of number of documentation of prescription drug monitoring program (CURES) results	baseline, 1, 3- and 6-months and 12 months	change of number of documentation of prescription drug monitoring program (CURES) results
change of number of signed opioid informed consent forms	baseline, 1, 3- and 6-months and 12 months	change of number of signed opioid informed consent forms

Secondary Outcome Measures

Name	Time	Method
Change in number of patients on long-term high risk doses of opioid pain medications	baseline, 1, 3- and 6-months and 12 months	decreases in daily dose of opioids and number of patients on opioids ≥ 90mg MEDD

Trial Locations

Locations (1)

Stanford University; 🇺🇸 Stanford, California, United States